Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.

BACKGROUND: Patients undergoing dialysis usually have a poor response to conventional hepatitis B vaccination. AIM: To observe the effects of intradermal hepatitis B (HB) vaccination in a 13-month prospective study of adult patients with end-stage renal failure. The patients were with or without previous hepatitis B vaccination, but all had antibody titres <10 mUI/mL. METHODS: Patients were allotted to two groups: previous hepatitis B virus vaccination and no previous hepatitis B virus vaccination or anti-HBs titres <10 mUI/mL. Patients in both groups received 16 i.d. injections of 0.1 mL of hepatitis B virus vaccine over an eight-week period. Patients had antibody titres assessed before vaccination, 1 month after and every 3 months for a year. Antibody titres >/=10 mUI/mL were considered protective. RESULTS: Seventy patients completed the protocol. Protective titres were elicited in 82% of each group. Age, time under dialysis, diabetes, smoking and body-mass index were not associated with seroconversion. Persistent protective titres >12 months occurred in 27 (58.7%). Adverse events were trivial. CONCLUSION: Intradermal hepatitis B virus vaccination is an alternative in end-stage renal failure.

[AIDS patients' compliance with antiretroviral treatment: notified difficulties and measures for improvement at a teaching hospital]. / Adesão de pacientes com AIDS ao tratamento com antiretrovirais: dificuldades relatadas e proposiçao de medidas atenuantes em um hospital escola.

This study aimed at identifying the incidence of drug intake errors and the main therapy-related difficulties among AIDS patients as well as at proposing measures to increase patients' adherence to treatment. Sixty-one patients with AIDS assisted by the University Hospital of São Paulo State University at Campinas were interviewed. The most frequent errors concerned the combinations of drugs and the length of fasting. The difficulties reported were adverse effects and the variety of drugs. Based on these data, the authors proposed the use of an illustrated guide for drug-related information. It is hoped that individualized guidance can contribute to minimize errors concerning adherence to therapy.